» Articles » PMID: 36253014

Metabolomic Markers of Glucose Regulation After a Lifestyle Intervention in Prediabetes

Overview
Specialty Endocrinology
Date 2022 Oct 17
PMID 36253014
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Disentangling the specific factors that regulate glycemia from prediabetes to normoglycemia could improve type 2 diabetes prevention strategies. Metabolomics provides substantial insights into the biological understanding of environmental factors such as diet. This study aimed to identify metabolomic markers of regression to normoglycemia in the context of a lifestyle intervention (LSI) in individuals with prediabetes.

Research Design And Methods: We conducted a single-arm intervention study with 24 weeks of follow-up. Eligible study participants had at least one prediabetes criteria according to the American Diabetes Association guidelines, and body mass index between 25 and 45 kg/m. LSI refers to a hypocaloric diet and >150 min of physical activity per week. Regression to normoglycemia (RNGR) was defined as achieving hemoglobin A1c (HbA1c) <5.5% in the final visit. Baseline and postintervention plasma metabolomic profiles were measured using liquid chromatography-tandem mass spectrometry. To select metabolites associated with RNGR, we conducted the least absolute shrinkage and selection operator-penalized regressions.

Results: The final sample was composed of 82 study participants. Changes in three metabolites were significantly associated with regression to normoglycemia; N-acetyl-D-galactosamine (OR=0.54; 95% CI 0.32 to 0.82), putrescine (OR=0.90, 95% CI 0.81 to 0.98), and 7-methylguanine (OR=1.06; 95% CI 1.02 to 1.17), independent of HbA1c and weight loss. In addition, metabolomic perturbations due to LSI displayed enrichment of taurine and hypotaurine metabolism pathway (p=0.03) compatible with biomarkers of protein consumption, lower red meat and animal fats and higher seafood and vegetables.

Conclusions: Evidence from this study suggests that specific metabolomic markers have an influence on glucose regulation in individuals with prediabetes after 24 weeks of LSI independently of other treatment effects such as weight loss.

Citing Articles

Adaptation of the nutrition care process for metabolic diseases in the Mexican population.

Sevilla-Gonzalez M, Gonzalez-Ortiz A, Landa-Anell M, Melgarejo-Hernandez M, Arias-Marroquin A, Del Razo-Olvera F Front Nutr. 2025; 12:1513747.

PMID: 39980684 PMC: 11841437. DOI: 10.3389/fnut.2025.1513747.


Metabolomic Profile Alterations Associated with the Risk Haplotype Following a Lifestyle Intervention in People With Prediabetes.

Sevilla-Gonzalez M, Garibay-Gutierrez M, Vargas-Vazquez A, Medina-Garcia A, Ordonez-Sanchez M, Clish C Curr Dev Nutr. 2024; 8(9):104444.

PMID: 39310668 PMC: 11416210. DOI: 10.1016/j.cdnut.2024.104444.


Maternal and Child Health, Non-Communicable Diseases and Metabolites.

Cerf M Metabolites. 2023; 13(6).

PMID: 37367913 PMC: 10301031. DOI: 10.3390/metabo13060756.


Postmortem Metabolomics of Insulin Intoxications and the Potential Application to Find Hypoglycemia-Related Deaths.

Ward L, Engvall G, Green H, Kugelberg F, Soderberg C, Elmsjo A Metabolites. 2023; 13(1).

PMID: 36676928 PMC: 9912265. DOI: 10.3390/metabo13010005.

References
1.
Perreault L, Temprosa M, Mather K, Horton E, Kitabchi A, Larkin M . Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. Diabetes Care. 2014; 37(9):2622-31. PMC: 4140157. DOI: 10.2337/dc14-0656. View

2.
Fiamoncini J, Rundle M, Gibbons H, Thomas E, Geillinger-Kastle K, Bunzel D . Plasma metabolome analysis identifies distinct human metabotypes in the postprandial state with different susceptibility to weight loss-mediated metabolic improvements. FASEB J. 2018; 32(10):5447-5458. DOI: 10.1096/fj.201800330R. View

3.
Akinkuolie A, Buring J, Ridker P, Mora S . A novel protein glycan biomarker and future cardiovascular disease events. J Am Heart Assoc. 2014; 3(5):e001221. PMC: 4323825. DOI: 10.1161/JAHA.114.001221. View

4.
Akinkuolie A, Pradhan A, Buring J, Ridker P, Mora S . Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2015; 35(6):1544-50. PMC: 4441588. DOI: 10.1161/ATVBAHA.115.305635. View

5.
Tsuchiya Y, Kawamata K . Effects of taurine on plasma glucose concentration and active glucose transport in the small intestine. Anim Sci J. 2017; 88(11):1763-1767. DOI: 10.1111/asj.12829. View